Zde se nacházíte:
Informace o publikaci
Relugolix kombinovaná terapie a symptomy děložní myomatózy - vybrané kazuistiky indikačního spektra a výsledků léčby
Autoři | |
---|---|
Rok publikování | 2023 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY |
Fakulta / Pracoviště MU | |
Citace | |
www | https://www.prolekare.cz/casopisy/ceska-gynekologie/2023-5-6/relugolix-kombinovana-terapie-a-symptomy-delozni-myomatozy-vybrane-kazuistiky-indikacniho-spektra-a-vysledku-lecby-135551 |
Doi | http://dx.doi.org/10.48095/cccg2023359 |
Klíčová slova | relugolix combination therapy; uterine fibroid symptoms |
Popis | Objective: An illustrative review of the indications for relugolix combination therapy (RCT) in the management of symptoms associated with uterine myomatosis. Methods: A set of annotated case reports from outpatient and clinical practice. Results: The file includes a non-invasive methodology for defining excessive menstrual bleeding using the pictorial bleeding assessment chart (PBAC). It also presents the use of RCT as a fertility-sparing procedure prior to elective myomectomy and the management of isthmic fi broids as an uterine factor of infertility. Cases of RCT of adenomyosis in primary sterility and in extragenital forms of endometriosis are commented. Emergent events associated with complications of myomatosis in pregnancy are represented by a case report of necrotizing diffuse myomatosis in puerperium. The differential-diagnostic confusion of adnexal pathology and myomatosis, RCT as a final solution to failed pharmacotherapy, and the alternative of hysterectomy in premenopause illustrate the diverse spectrum of indications for pharmacological treatment, including the possibility of dual therapy with RCT and aGnRH. Conclusion: Relugolix combination therapy as an effective and safe causal treatment expands the therapeutic spectrum and options for reproductive medicine specialists and registering gynaecologists. The availability of conservative treatment in combination with surgical treatment leads to optimalization and greater effectiveness of therapeutic procedures and increased quality of life for women with myomatosis. |